Dr. Eugene Greenberg Digestive Health Institute provides a comprehensive approach to each patient through screenings, medical and surgical therapies, as well as nutritional, social, and other support services. Our specialists focus on taking care of each patient from diagnosis through therapy and treatment. Carle Digestive Health Institute also participates in clinical trials to help further advance medicine and bring tomorrow's cures to today's patients.
Carle colorectal specialists treat conditions that affect the small intestines, colon, rectum and anus, in addition to GI cancers.
Our team of specialists is dedicated to taking care of each patient from the diagnosis stages through the therapy and treatment of a range of Digestive Health disorders.
Carle Digestive Health experts can help you determine when random discomfort becomes a cause for concern.
With a team approach to care, experts at Carle Cancer Center develop an individualized plan of treatment for patients with gastrointestinal cancer.
Patients with liver disease can receive specialized care and treatment from expert Carle providers.
The Carle care team will help you manage your Crohn’s disease and ulcerative colitis symptoms and improve your quality of life.
Carle providers offer advanced diagnostic and therapeutic techniques for diseases specific to the pancreas, gallbladder and bile ducts.
Have a patient referral? Refer a patient now.
At Carle, we understand the importance of research and the role research plays in providing quality care to our patients. Research initiatives offer new information about how to combat disease, show new ways of thinking about treatment and possible cures. Carle physicians also partner with scientists at the University of Illinois to study evolving fields in the science of microbiomes, inflammatory bowel disease, C diff, constipation, and other gut related illnesses.
Carle Digestive Health physicians are involved in many ongoing clinical research studies and clinical trials for Inflammatory Bowel Disease (IBD), including Crohn's Disease and Ulcerative Colitis.
Our skilled physicians are invested in this research to further understand these chronic, sometimes debilitating gastrointestinal (GI) diseases and conditions. To learn more about digestive health research, visit our list of clinical trials or call (844) 37-RESEARCH (844-377-3732) or email us.
The investigators wish to study the effects of three forms of bariatric surgery: gastric bypass, sleeve gastrectomy, and lap banding. The surgery is not part of the clinical trial. If insurance does not cover the procedure, then the patient is responsible for payment of the surgical process. The investigators are doing pre- and post-surgery testing to provide a better understanding of the effect of bariatric surgery-induced weight loss on 1) alcohol absorption, distribution and elimination from the body; 2) the effects of alcohol on blood sugar; and 3) the effects of alcohol on mood.
This registry will prospectively enroll 4,000 patients who undergo FMT at 75 sites throughout North America. Information on FMT methodology employed (e.g., screening of donor and recipient, preparation, FMT delivery) will be collected from each site. The indication for FMT as well as baseline information on recipient will also be collected. Following FMT, patients will be followed at regular intervals up to 10 years post FMT. This will include follow-up information from the patient's healthcare provider at 1 month, 6 months, 1 year, and 2 years after FMT as well as direct communication with patients at least annually up to 10 years after FMT. Follow-up information collected will be designed to assess potential short-term and long-term safety and effectiveness.
The purpose of this study is to evaluate the combined remission of complex perianal fistulas, defined as the clinical assessment at Week 24 of closure of all treated external openings that were draining at baseline despite gentle finger compression, and absence of collections greater than (>) 2 centimeter (cm) (in at least 2 dimensions) confirmed by blinded central magnetic resonance imaging (MRI) assessment at Week 24.
With doctors practicing in 80 specialties at locations throughout the region, it’s easy to find the right healthcare team at Carle. Our mission is to serve people through high quality care, medical research and education.
Charitable gifts are used for numerous projects and programs that enhance the healthcare experience for digestive health patients and their loved ones. With your support, we’ll expand the scope of services offered and further Carle’s dedication to the diagnosis and treatment of digestive issues.
Recognized among the nation’s top hospitals, Carle provides excellent healthcare while continuously improving to meet the needs of our patients.